Classifying new anti-tuberculosis drugs: rationale and future perspectives

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Classifying new anti-tuberculosis drugs: rationale and future perspectives
Authors
Keywords
Anti-TB drugs, MDR/XDR-TB, Fluoroquinolones, Linezolid, Bedaquiline, Delamanid ;
Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 56, Issue -, Pages 181-184
Publisher
Elsevier BV
Online
2016-11-04
DOI
10.1016/j.ijid.2016.10.026

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.